Neuronetics (STIM) Invested Capital (2016 - 2026)

Neuronetics (STIM) has 11 years of Invested Capital data on file, last reported at $13.5 million in Q1 2026.

• Quarterly Invested Capital fell 66.66% year-over-year to $13.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.5 million (down 66.66% YoY) and the FY2025 annual result came in at $26.7 million, down 18.47% from the prior year.
• Invested Capital fell to $13.5 million in Q1 2026 per STIM's latest filing, from $26.7 million in the prior quarter.
• Across five years, Invested Capital topped out at $76.6 million in Q1 2022 and bottomed at $9.4 million in Q3 2024.
• The 5-year median for Invested Capital is $34.2 million (2023), against an average of $41.3 million.
• The widest annual swing landed in 2024, when Invested Capital sank 75.27%; it then jumped 202.27% in 2025.
• Tracing STIM's Invested Capital over 5 years: stood at $70.2 million in 2022, then plunged by 51.29% to $34.2 million in 2023, then fell by 4.07% to $32.8 million in 2024, then dropped by 18.47% to $26.7 million in 2025, then tumbled by 49.46% to $13.5 million in 2026.
• Per Business Quant, the three latest STIM Invested Capital figures stand at $13.5 million (Q1 2026), $26.7 million (Q4 2025), and $28.4 million (Q3 2025).

Peer Comparison